Reports

Drug name	NICE TAs	Comments
Salicylic acid 5% w/w / propylene glycol 47.5% w/w in Dermovate® cream		Unlicensed special
Salicylic acid 5% w/w in emulsifying ointment		Unlicensed special
Sapropterin dihydrochloride (Kuvan)	TA729 - Sapropterin for treating hyperphenylalaninaemia in phenylketonuria
Sarilumab	TA485 - Sarilumab for moderate to severe rheumatoid arthritis
Sebelipase alfa (Kanuma®)		For Wolman disease
Secukinumab	TA350 - Secukinumab for treating moderate to severe plaque psoriasis TA719 - Secukinumab for treating non-radiographic axial spondyloarthritis TA734 - Secukinumab for treating moderate to severe plaque psoriasis in children and young people TA935 - Secukinumab for treating moderate to severe hidradenitis suppurativa
Selenium injection
Selpercatinib (Retsevmo®)	TA760 - Selpercatinib for previously treated RET fusion-positive advanced non-small cell lung cancer TA911 - Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer NICE TA 1038 Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over NICE TA 1039 Selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer drug in people 12 years and over NICE TA 1042 Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer
Semaglutide (Wegovy®)	TA875 - Semaglutide for managing overweight and obesity	The use of semaglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management service with a commercial agreement in place. Prescribe by brand (Wegovy®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes. The Wegovy® brand of semaglutide is not commercially available yet.
Sevoflurane

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports